全国微创胰十二指肠切除术后胰瘘率:NSQIP分析
该研究基于NSQIP胰腺切除术靶向数据库2014–2017年1096例择期微创胰十二指肠切除术(MIPD)患者,分析胰瘘率随时间的变化趋势。结果显示胰瘘率和临床相关胰瘘率均逐年显著下降,手术年份增加是独立保护因素,但趋势仅见于无胰腺导管<3 mm或胰腺质地柔软的低危患者。
要点
- MIPD术后胰瘘率逐年下降,2014至2017年从23.6%降至12.7%。
- 临床相关胰瘘率同样逐年下降,从18.3%降至9.1%。
- 手术年份增加是胰瘘的独立保护因素(OR 0.76/年)。
核心结论
- 全国MIPD术后胰瘘率随时间改善,主要归因于低危患者结局的改善。
研究设计与样本
- 回顾性队列研究,纳入2014–2017年NSQIP胰腺切除术靶向数据库中所有择期MIPD患者,共1096例。
主要发现
- 胰瘘率逐年显著下降:23.6% vs 19.2% vs 14.9% vs 12.7%,p<0.01。
- 临床相关胰瘘率逐年显著下降:18.3% vs 15.4% vs 11.1% vs 9.1%,p<0.01。
- 多变量分析中,手术年份增加是胰瘘的独立保护因素(OR 0.76/年,p<0.01)。
- 手术年份增加是临床相关胰瘘的独立保护因素(OR 0.73/年,p<0.01)。
- 无胰腺导管<3 mm或胰腺质地柔软的患者,胰瘘率逐年显著下降(23.7% vs 13.2% vs 10.3% vs 8.0%,p<0.01),临床相关胰瘘率亦显著下降(18.3% vs 9.1% vs 5.2% vs 6.0%,p<0.01)。
关键数值与推荐
- 胰瘘率逐年比较采用Cochran-Armitage和Mann-Kendall趋势检验。
- 多变量逻辑回归用于评估手术年份与胰瘘的独立关联。
临床怎么用
- MIPD术后胰瘘率在全国范围内呈改善趋势,提示学习曲线和技术演进可能带来获益。
- 对于胰腺导管<3 mm或胰腺质地柔软的高危患者,胰瘘率未见显著下降趋势,需持续关注。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is a substantial learning curve associated with minimally invasive pancreaticoduodenectomy (MIPD). We sought to determine if national MIPD pancreatic fistula rates are decreasing with time. STUDY DESIGN: All patients undergoing elective MIPD and accrued into the pancreatectomy-targeted NSQIP database between 2014 and 2017 were included in the study. Trends in MIPD outcomes by year were examined using Cochran-Armitage and Mann-Kendall tests for trend. Multivariable logistic regression was used to assess for an independent association between increasing year of operation and pancreatic fistula. RESULTS: There were 1,096 patients who underwent MIPD between 2014 and 2017. There was a significant trend toward decreasing pancreatic fistula rates (23.6% vs 19.2% vs 14.9% vs 12.7%, p < 0.01) and clinically relevant pancreatic fistula rates (18.3% vs 15.4% vs 11.1% vs 9.1%, p < 0.01) by increasing year. In multivariable analysis, increasing year of operation was independently protective against pancreatic fistula (odds ratio [OR] 0.76 per year, p < 0.01) and clinically relevant pancreatic fistula (OR 0.73 per year, p < 0.01). Patients without pancreas ducts < 3 mm or soft pancreas gland texture experienced a significant decreasing trend in pancreatic fistula rates (23.7% vs 13.2% vs 10.3% vs 8.0%, p < 0.01) and clinically relevant pancreatic fistula rates (18.3% vs 9.1% vs 5.2% vs 6.0%, p < 0.01), respectively, by increasing year. However, there was not a significant trend in pancreatic fistula rate or clinically relevant fistula rate among patients having either pancreas ducts < 3 mm or soft gland texture. CONCLUSIONS: National MIPD pancreatic fistula rates are improving with time. A major contributing factor for this finding is better outcomes in patients who are at lower risk of pancreatic fistula, which could be a reflection of evolving minimally invasive anastomotic techniques.
引用
- Panni RZ, Guerra J, Hawkins WG, et al. National Pancreatic Fistula Rates after Minimally Invasive Pancreaticoduodenectomy: A NSQIP Analysis. J Am Coll Surg. 2019. PMID: 30797082. doi:10.1016/j.jamcollsurg.2019.02.042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。